Avicanna CEO to Present at Life Sciences Investor Forum

• Aras Azadian will present at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com.
• The presentation is scheduled for Sep 17th at 10:30 am Eastern Time.
• The forum runs as a live, interactive online event.
• A webcast replay will be available following the conclusion of the conference.
• Investor inquiries can be directed to Ivana Maric at ir@avicanna.com.

Presentation Details

Aras Azadian will present at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com. The presentation is set for Sep 17th at 10:30 am Eastern Time. The forum runs as a live, interactive online event.

Access

A webcast replay will be available following the conclusion of the conference. Investors can direct questions to Ivana Maric at ir@avicanna.com.

Company Profile

Avicanna Inc. is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. The company is organized around four business pillars and markets more than thirty proprietary products. Avicanna filed its annual information form dated March 31, 2026.

Subsidiaries and Brands

MyMedi.ca is a medical cannabis care platform formed to better serve medical cannabis patients' needs and enhance their journey. The platform is operated by Northern Green Canada Inc.. Santa Marta Golden Hemp SAS is a majority owned subsidiary of Avicanna. RHO Phyto is an established brand in Canada, currently available nationwide across several channels and expanding into new international markets.